A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine

Amaal J. Starling; Bert B. Vargas

doi:10.1007/s11916-015-0521-0

A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine

Amaal J. Starling, Bert B. Vargas

Research output: Contribution to journal › Review article › peer-review

14 Scopus citations

Abstract

Chronic migraine is a debilitating disorder that affects 2 % of the global population and imparts a significant societal and economic impact. The cornerstones of chronic migraine management include making an accurate diagnosis, patient education, treatment of comorbid conditions, and selection of an appropriate, evidence-based acute and preventive treatment regimen. Although it is common to treat chronic migraine with preventive medications effective for episodic migraine, a number of treatment options exist with specific evidence for effectiveness in chronic migraine. Currently, onabotulinumtoxinA injections are the only FDA-approved preventive treatment for chronic migraine. A number of non-medication treatment options including occipital nerve and supraorbital nerve stimulation have shown promise as effective prevention for patients either unable to tolerate or unable to obtain relief from oral medications, but more research is necessary.

Original language	English (US)
Article number	49
Journal	Current pain and headache reports
Volume	19
Issue number	10
DOIs	https://doi.org/10.1007/s11916-015-0521-0
State	Published - Oct 21 2015

Keywords

Chronic daily headache
Chronic migraine
Headache
Migraine
Treatment

ASJC Scopus subject areas

Clinical Neurology
Anesthesiology and Pain Medicine

Access to Document

10.1007/s11916-015-0521-0

Cite this

@article{65f56edca76a4d67a04a5b4c69eaf12e,

title = "A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine",

abstract = "Chronic migraine is a debilitating disorder that affects 2 % of the global population and imparts a significant societal and economic impact. The cornerstones of chronic migraine management include making an accurate diagnosis, patient education, treatment of comorbid conditions, and selection of an appropriate, evidence-based acute and preventive treatment regimen. Although it is common to treat chronic migraine with preventive medications effective for episodic migraine, a number of treatment options exist with specific evidence for effectiveness in chronic migraine. Currently, onabotulinumtoxinA injections are the only FDA-approved preventive treatment for chronic migraine. A number of non-medication treatment options including occipital nerve and supraorbital nerve stimulation have shown promise as effective prevention for patients either unable to tolerate or unable to obtain relief from oral medications, but more research is necessary.",

keywords = "Chronic daily headache, Chronic migraine, Headache, Migraine, Treatment",

author = "Starling, {Amaal J.} and Vargas, {Bert B.}",

note = "Publisher Copyright: {\textcopyright} 2015, Springer Science+Business Media New York.",

year = "2015",

month = oct,

day = "21",

doi = "10.1007/s11916-015-0521-0",

language = "English (US)",

volume = "19",

journal = "Current pain and headache reports",

issn = "1531-3433",

publisher = "Current Science, Inc.",

number = "10",

}

TY - JOUR

T1 - A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine

AU - Starling, Amaal J.

AU - Vargas, Bert B.

PY - 2015/10/21

Y1 - 2015/10/21

N2 - Chronic migraine is a debilitating disorder that affects 2 % of the global population and imparts a significant societal and economic impact. The cornerstones of chronic migraine management include making an accurate diagnosis, patient education, treatment of comorbid conditions, and selection of an appropriate, evidence-based acute and preventive treatment regimen. Although it is common to treat chronic migraine with preventive medications effective for episodic migraine, a number of treatment options exist with specific evidence for effectiveness in chronic migraine. Currently, onabotulinumtoxinA injections are the only FDA-approved preventive treatment for chronic migraine. A number of non-medication treatment options including occipital nerve and supraorbital nerve stimulation have shown promise as effective prevention for patients either unable to tolerate or unable to obtain relief from oral medications, but more research is necessary.

AB - Chronic migraine is a debilitating disorder that affects 2 % of the global population and imparts a significant societal and economic impact. The cornerstones of chronic migraine management include making an accurate diagnosis, patient education, treatment of comorbid conditions, and selection of an appropriate, evidence-based acute and preventive treatment regimen. Although it is common to treat chronic migraine with preventive medications effective for episodic migraine, a number of treatment options exist with specific evidence for effectiveness in chronic migraine. Currently, onabotulinumtoxinA injections are the only FDA-approved preventive treatment for chronic migraine. A number of non-medication treatment options including occipital nerve and supraorbital nerve stimulation have shown promise as effective prevention for patients either unable to tolerate or unable to obtain relief from oral medications, but more research is necessary.

KW - Chronic daily headache

KW - Chronic migraine

KW - Headache

KW - Migraine

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84939621293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939621293&partnerID=8YFLogxK

U2 - 10.1007/s11916-015-0521-0

DO - 10.1007/s11916-015-0521-0

M3 - Review article

C2 - 26286071

AN - SCOPUS:84939621293

SN - 1531-3433

VL - 19

JO - Current pain and headache reports

JF - Current pain and headache reports

IS - 10

M1 - 49

ER -

A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this